Atlas Trials

A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma

Clinical trial NCT00606008 · COMPLETED

Trial details

NCT number
NCT00606008
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anaplastic AstrocytomaGlioblastoma
Start date
2007-03-01
Primary completion
2012-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.